Navigation Links
Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
Date:10/25/2007

he same periods in 2006.

Marketing, general and administrative expense was approximately $2.9 million and $8.8 million for the three and nine months ended September 30, 2007, respectively, compared to approximately $2.6 million and $8.2 million for the same periods in 2006. The increase primarily reflects an increase in compensation costs associated with additional commercial and administrative personnel and additional stock-based compensation; offset by a decrease in consulting and outside services related to a software implementation project and strategic marketing programs expensed in 2006. Total stock-based compensation included in marketing, general and administrative expense was approximately $601,000 and $1.8 million for the three and nine months ended September 30, 2007, respectively, compared to approximately $577,000 and $1.5 million for the same periods in 2006.

As of September 30, 2007, cash, cash equivalents and short term investments were approximately $20.9 million, compared to $42.4 million at December 31, 2006. The decrease resulted primarily from net cash used to fund ongoing operations partially offset by the $10 million in gross proceeds from the registered direct offering of common stock in February 2007.

"We expect total operating expenses for the full year 2007 to be approximately $50 million, including an estimated $5 million in stock-based compensation," said Tamara A. Seymour, Chief Financial Officer of Favrille. "We believe our cash on hand along with access to our committed equity financing facility should be sufficient to fund operations through the first half of 2008."

Conference Call and Webcast Information

Favrille management will host a conference call today to discuss the third quarter 2007 financial results at 5:00 p.m. Eastern Time. A live audio webcast of management's presentation will be available at http://www.favrille.com. Alternatively, callers
'/>"/>

SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Favrille Announces Data From Phase 2 Clinical Trial of FavId for Indolent B-Cell Non-Hodgkins Lymphoma in Europe
2. Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma
3. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
4. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
5. XTL Provides Update on Phase I Clinical Trial of XTL-2125
6. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
7. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
8. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
9. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
10. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
11. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013  Technology advances have had a profound ... a constantly evolving communication environment, companies need to ... with internal executives. It is challenging, however, to ... and tools that are part of today,s communication ... Best Practices, LLC explores the various internal communication ...
(Date:5/17/2013)... May 17, 2013 Research ... and outcomes research also   to   be presented ... SHPG ), the global specialty biopharmaceutical company, announces ... presentations at the American Psychiatric Association (APA) 166th Annual ... 18-22. The data being presented represent Shire,s ongoing commitment ...
(Date:5/17/2013)... May 17, 2013 Fuse Science, Inc. (OTCQB: DROP), ... that is developing new, patent-pending technologies poised to redefine how ... it will hold a business update teleconference and webcast for ... , 2013 at 4:30 PM ET. Fuse ... host the call and will be joined by ...
Breaking Medicine Technology:Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2
... 20, 2011 Artegraft, Inc. announces that a three-year ... issue of the Journal of Vascular Surgery ... grafts (BCA) to cuffed ePTFE grafts. Conducted at Massachusetts ... had significantly higher primary and assisted patency rates than ...
... July 20, 2011 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... the development and commercialization of products for central nervous ... the second quarter of 2011, on Thursday, August 4, ... of the release will be disseminated at that time. ...
Cached Medicine Technology:Study Published in Journal of Vascular Surgery Confirms Superiority of Artegraft BCA to Cuffed ePTFE for Hemodialysis Access 2Vanda Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011 2
(Date:5/19/2013)... The Pradaxa lawyers at Bernstein Liebhard ... convened for hundreds of Pradaxa bleeding lawsuits ... U.S. District Court, Southern District of Illinois. According ... 14th, the Conference addressed the status of depositions and ... Conference that Defendants submitted a list of early trial ...
(Date:5/19/2013)... 2013 Dr. Keith Chertok now provides gum ... unhealthy gums and increase the chance of a healthier smile. ... Attachment Procedure (LANAP) not only removes diseased gum tissue in ... jaw bone for dental implants. , LANAP uses ... It can also help stimulate the healthy tissue as well ...
(Date:5/19/2013)... Yeast infections are common in both men and women. ... human body. A new yeast infection treatment product has been ... method of application to help eliminate over growth of the ... men and women searching for a natural process of yeast ... food and is stored in the intestines. In small consumable ...
(Date:5/19/2013)... Malibu, CA (PRWEB) May 19, 2013 ... model addiction treatment center, has announced this week the ... completely through the brands’ social media channels. “We ... the addiction treatment community and to get feedback regarding ... Pax Prentiss, CEO and co-founder of the Passages ...
(Date:5/19/2013)... 2013 The AMTC team will be screening ... Georgia Convention & Trade Center on June 1st. Professionals and ... auditions are free of charge. , Actors, Models and Talent ... of successful artists and grads like Caitlin Kinney - SYTYCD, ... , Chris Young - on his Liquid Neon 2013 Tour, ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2
... latest NHS news it is said that the breast cancer drug ... patients. But this is not happy news to the grieving family ... breast cancer. But NHS officials denied her the drug which led ... ,By profession she was an advertising art director from ...
... a plan to improve the bedside manners of would-be doctors. ... will be "embedded" with patients suffering from a chronic illness ... ,This program will be compulsory for the students and ... the US. "I think it would be ideal to have ...
... shaky from terror bombings and the 2004 tsunami, was ... parts of this Javanese cultural city, a prime tourist ... its cultural history, temples and vibrant arts and crafts ... overseas tourists. ,"We're suffering another setback," said ...
... claimed that ancient trees could provide clues to the pattern of ... Pingri, 75, from Guangdong Academy of Sciences has opined that rising ... but in fact was a part of the cyclical order of ... ancient trees, I discovered the temperature throughout history has risen and ...
... Initiated by their professor - high school and college students ... ,Isolation and characterisation of 30 macrophages has been made ... Genetics issue of June 9, 2006 has a report of ... the University of Pittsburgh. The report is about the characterization ...
... colleagues at the Indiana University Medical Center, Indianapolis say ... into having unwanted sex //. ,Unwanted sex ... researchers write in the June issue of the Archives ... result in risk for sexually transmitted infections and pregnancies. ...
Cached Medicine News:Health News:Indonesian Tourism on Downward Trend After Java Quake 2